Search results

Found 730 pages
AUTHOR: Lucy Parsons

Results per page

10 20 50 100

Sort by

Relevance Date

14 Jun 2021:

NICE to reassess Kyowa Kirin’s Poteligeo

An appeal lodged by the company and various charities has been upheld by an independent appeal panel - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/nice_to_reassess_kyowa_kirins_poteligeo_1371577

25 Feb 2021:

Moderna sends South Africa variant-specific vaccine for clinical study

Modified vaccine candidate shipped to the US National Institutes of Health (NIH) - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/moderna_sends_south_africa_variant-specific_vaccine_for_clinical_study_1364129

11 Jun 2021:

NICE broadens access to treatments for rheumatoid arthritis

New guidance enables earlier access to certain treatments, including biologics - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/nice_broadens_access_to_treatments_for_rheumatoid_arthritis_1371520

18 Jun 2021:

Pfizer’s JAK inhibitor Xeljanz shows benefit in COVID-19 pneumonia

Xeljanz reduced the incidence of death or respiratory failure compared to placebo in hospitalised patients - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/pfizers_jak_inhibitor_xeljanz_shows_benefit_in_covid-19_pneumonia_1371825

8 Jan 2021:

Tocilizumab and sarilumab cut risk of death in severe COVID-19…

Anti-inflammatory drugs also accelerated patients' recovery times - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/tocilizumab_and_sarilumab_cut_risk_of_death_in_severe_covid-19_patients_1360960

16 Mar 2021:

Frontline charities sign open letter backing COVID-19 vaccination…

Over 20 charities are encouraging people with underlying conditions to receive a jab - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/frontline_charities_sign_open_letter_backing_covid-19_vaccination_drive_1365299

17 Jun 2021:

NICE backs Lilly’s Taltz for axial spondyloarthritis

Drug has been cleared for use in patients whose condition is not controlled well enough with conventional therapy - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/nice_backs_lillys_taltz_for_axial_spondyloarthritis_1371749

5 Mar 2021:

Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says …

UK’s regulatory authority will fast-track jabs modified to new variants - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/modified_covid-19_vaccines_can_avoid_lengthy_clinical_studies,_says_mhra_1364671

10 Jun 2021:

Opdivo combos show OS benefit in advanced oesophageal cancer

Opdivo plus chemotherapy or Yervoy demonstrated overall survival benefit in PD-L1-positive and all-randomised populations - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/opdivo_combos_show_os_benefit_in_advanced_oesophageal_cancer_1371457

15 Jun 2021:

AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant

New real world data from PHE shows vaccines can protect against hospitalisation caused by variant - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/az,_pfizerbiontech_vaccines_highly_effective_against_delta_variant_1371652